Early blood profiles of virus infection in a monkey model for Lassa fever.

scientific article published on 23 May 2007

Early blood profiles of virus infection in a monkey model for Lassa fever. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.00536-07
P932PMC publication ID1951294
P698PubMed publication ID17522210

P50authorJuan C ZapataQ63378737
Igor S LukashevichQ89978578
P2093author name stringOswald R Crasta
Otto Folkerts
Zhangjun Fei
Maria S Salvato
Marti Jett
Rasha Hammamieh
Bruno Sobral
Joseph Bryant
C David Pauza
Harry Davis
Mark Swindells
Mahmoud M Djavani
P2860cites workViperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirusQ24292060
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effectorQ24316159
Expression of the interferon-alpha/beta-inducible bovine Mx1 dynamin interferes with replication of rabies virusQ24337511
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsQ24597089
On the front lines of Lassa feverQ24599583
A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancyQ24675684
Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phaseQ24792264
Identification and utilization of inter-species conserved (ISC) probesets on Affymetrix human GeneChip platforms for the optimization of the assessment of expression patterns in non human primate (NHP) samplesQ24793314
Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA ReplicationQ27470314
Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodiesQ28206468
Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88Q28646151
affy--analysis of Affymetrix GeneChip data at the probe levelQ29547353
Hematologic dysfunction in Lassa feverQ33448183
Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokinesQ33755013
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus.Q33781829
The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent mannerQ33801521
Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent eventsQ33839711
Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virusQ33842651
Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAsQ33870381
Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1Q34302223
LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regenerationQ34338137
Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cellsQ34341267
Do pathogens accelerate atherosclerosis?Q34389205
Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cellsQ34424726
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulenceQ34434866
Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.Q34467311
Interleukin-1, neuroinflammation, and Alzheimer's diseaseQ34469514
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virusQ34647754
Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.Q35024355
Differential signaling networks induced by mild and lethal hemorrhagic fever virus infectionsQ35101515
Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomicsQ35139200
Timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of miceQ35763835
Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2Q36369190
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.Q36681272
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virusQ36701093
Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.Q36925354
Myristoylation of the RING finger Z protein is essential for arenavirus buddingQ37568060
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate modelQ37585469
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.Q37596973
Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesvirusesQ38343679
Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expressionQ38571526
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrastedQ38663795
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.Q38973017
Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivoQ39002185
Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesisQ39683810
T-Cell-Mediated Immunopathology in Viral InfectionsQ39943334
Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer.Q40254226
Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2 alpha, and c-Jun N-terminal kinase by a neurovirulent murine retrovirusQ40394829
Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteinsQ40400483
Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics.Q40462980
Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1.Q40478465
Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infectionQ40552244
The use of interferon for emergency prophylaxis of marburg hemorrhagic fever in monkeys.Q40593915
Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa feverQ40602416
Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs.Q40693235
A plasma inhibitor of platelet aggregation in patients with Lassa feverQ40772339
Experimental studies of arenaviral hemorrhagic feversQ40802232
Lassa virus hepatitis: a study of fatal Lassa fever in humansQ40809779
Pathogenicity of the Lassa virus for laboratory miceQ40815386
Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways.Q40847997
Interferon induction and/or production and its suppression by influenza A virusesQ41058470
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virusQ41847342
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult miceQ42004309
Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection.Q45083421
COX-2 inhibitors--lessons in drug safetyQ45267551
Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy.Q45495234
CD8 T cell responses to lymphocytic choriomeningitis virus in early growth response gene 1-deficient miceQ45592005
Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions.Q45779139
Infection of guinea pigs with two strains of lymphocytic choriomeningitis virus.Q45852113
Factors affecting plaque formation by Lassa virus in Vero cellsQ50240790
CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus.Q53629031
CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infectionQ56798247
Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2Q64379203
EXPERIMENTAL INHALATION INFECTION OF MONKEYS OF THE MACACUS CYNOMOLGUS AND MACACUS RHESUS SPECIES WITH THE VIRUS OF LYMPHOCYTIC CHORIOMENINGITIS (WE)Q76568244
A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycanQ77198723
Lassa feverQ78037746
A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary responseQ80542447
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectLassa feverQ706845
Lassa virusQ1806636
P304page(s)7960-7973
P577publication date2007-05-23
P1433published inJournal of VirologyQ1251128
P1476titleEarly blood profiles of virus infection in a monkey model for Lassa fever
P478volume81

Reverse relations

cites work (P2860)
Q30250910A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies.
Q41922365A Primate Model for Viral Hemorrhagic Fever
Q34647510A systems biology starter kit for arenaviruses
Q37434945A systems biology view of cancer
Q26823627Advanced vaccine candidates for Lassa fever
Q36387183Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes
Q36698306An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.
Q37033404Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection
Q90190052Animal Models of Lassa Fever
Q38064279Arenavirus evasion of host anti-viral responses
Q40285838Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.
Q33905046Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics
Q61817661Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF Pathogenesis
Q33959989Comparative pathogenesis and systems biology for biodefense virus vaccine development
Q35076680Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques
Q41922464Diagnostics for Lassa Fever: Detecting Host Antibody Responses.
Q37463214Fibroblastic reticular cells and their role in viral hemorrhagic fevers
Q40397175Gene expression in primate liver during viral hemorrhagic fever
Q35248863Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man
Q34266468Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses
Q38061425Host cell factors as antiviral targets in arenavirus infection
Q58109386Improving the Breadth of the Host's Immune Response to Lassa Virus
Q34515519Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection
Q37912497Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.
Q37103536Macaque models of human infectious disease
Q38615950Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection.
Q33524893Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection
Q34625899Pathogenesis of arenavirus hemorrhagic fevers
Q36155495Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro
Q37464889Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever
Q33656417Proteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha
Q33963386Reactive astrogliosis in response to hemorrhagic fever virus: microarray profile of Junin virus-infected human astrocytes
Q33549960Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infections
Q36970552Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
Q27666703Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression
Q63246534T-Cell Response to Viral Hemorrhagic Fevers
Q36806151The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection
Q27305228Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure
Q34999818Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate
Q37884343Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.
Q38823264Vaccine platforms to control Lassa fever
Q92815358Viral Strain Determines Disease Symptoms, Pathology, and Immune Response in Neonatal Rats with Lymphocytic Choriomeningitis Virus Infection

Search more.